> As for what this means for vaccines: It is by now widely accepted that a vaccination drastically reduces the effects of a COVID19 infection and all but elimin

> As for what this means for vaccines: It is by now widely accepted that a vaccination drastically reduces the effects of a COVID19 infection and all but eliminates the risk of fatal outcomes and that in billions of people vaccinated by billions of doses of various vaccines the side effects were negligibly small, and it is widely accepted that even in young healthy people, COVID19 can cause severe, even long-term cases. Therefore, the potential risks of vaccination are nowhere near as risky as risking the infection with the actual pathogen. The vaccination discussion you're trying to have has already been settled. The panel was not revisiting the approved 2-dose course. It was considering the benefits and risks of a third (booster) jab for individuals aged 16 and above. If you had listened to the panel, you'd understand the vote: there is not enough data at this time to conclude that the benefits outweigh the risks for a booster in such a broad group.